Medtrade partners with Dahlhausen® Medizintechnik to reach maternity units across Germany and Austria

Medtrade Products Ltd is delighted to announce that it has entered into an exclusive agreement with Dahlhausen^® Medizintechnik to distribute the revolutionary CELOX™ PPH Uterine Haemostatic Tamponade throughout Austria and Germany. CELOX PPH offers a unique, CE-certified solution for uterine postpartum haemorrhage (PPH), and Dahlhausen Medizintechnik’s extensive network will help more clinicians to access this vital solution to help manage postpartum bleeding.

 

PPH is a severe and prevalent complication of childbirth, and is the leading cause of maternal mortality worldwide, affecting approximately 14 million women and causing 80,000 deaths each year. Existing treatment options are limited, so CELOX PPH was designed to be easily and rapidly deployed in any setting, without the need for power, suction, saline or specific storage conditions. As documented in numerous peer-reviewed publications, the tamponade works quickly to provide effective haemostasis – demonstrating 100 % haemostasis for grade 1 and 2 bleeding (up to 2,500 ml) in all deliveries, and 95.6 % haemostasis for up to grade 3 bleeding (8,000 ml) in vaginal deliveries – while also reducing hysterectomy rates by 78 % compared to the current treatment options.

 

Dirk Rohmann, a member of the board at Dahlhausen, commented: “Dahlhausen is committed to supplying its customers with high quality medical technologies that address unmet clinical needs. We recognise the prevalence and severity of PPH, and we are proud to enter into this agreement with Medtrade to help overcome the limitations in current standards of care and progress the field of obstetrics.”

 

Russ Mably, the Chief Executive Officer at Medtrade Products Ltd, added: “This distribution agreement is a key step forward for Medtrade, and we look forward to working with Dahlhausen to continue to tackle the ongoing global challenge of postpartum bleeding. Our ambition is to make CELOX PPH tamponades an essential presence at every delivery across the world to improve obstetric outcomes, significantly reducing maternal mortality rates and improving patients’ quality of life.”

 

For more information, please visit https://www.celoxpph.com/ or contact us at info@celoxpph.com.

 

About Medtrade

Established in 1999, Medtrade is a UK-based biotechnology company developing and launching industry-leading solutions to partners across the world. With offices in Crewe, UK and New York, US, the highly experienced leadership and specialist teams are committed to supporting business partners and healthcare practitioners with market-leading solutions across women’s health, wound care, trauma and haemostasis sectors. Medtrade manages the entire product development process through to full product commercialisation. Integral to the success of Medtrade is the continued focus on innovation and a dedicated team is in place. New innovations aimed at addressing key global healthcare challenges such as biofilms, wound treatment, infection prevention, pressure injury prevention and control of bleeding are very much the focus. ISO 13485 certified, we have a successful legacy of providing market-leading solutions to brand owners and our success is built upon an enviable track record of quickly and efficiently supporting brand owners with key or flagship products in support of their strategic marketing objectives.

 

About Dahlhausen

Dahlhausen Medizintechnik ist Europas größter Komplettanbieter von klinischem Zubehör. Mit über 2500 verschiedenen Produkten decken wir den Bedarf von Chirurgie, Anästhesie und Pflege systematisch ab. Dabei sind wir nicht nur ein führender Fachhändler, sondern ein ebenso leistungsstarker und erfahrener Hersteller. Seit der Firmengründung 1845 gehört die Entwicklung und Produktion hochwertiger Medizintechnik zu unseren großen Stärken. Wir wissen: Der steigende Effizienzdruck im Gesundheitswesen ist für alle Beteiligten eine nachhaltige Herausforderung. Den Menschen mit ihren Ansprüchen gerecht zu werden, stellt einen täglichen Balanceakt dar. Gefragt ist daher Medizintechnik für effektive Arbeitsabläufe. Gefordert sind Lösungen, die nach vorne reichen. Dieser Aufgabe stellt sich unser Familienunternehmen bereits in vierter Generation. Neben unserer einzigartigen Sortimentsbreite sind wir auch bevorzugter Ansprechpartner und Problemlöser bei der Herstellung von Sonderanfertigungen. 1915 haben wir zum Beispiel als Erste mit der Herstellung serienmäßiger chirurgischer Instrumente begonnen. Heute bieten wir ein umfassendes Angebot eigener Qualitätsprodukte aus Deutschland. Dahlhausen Medizintechnik – ein Familienunternehmen mit Verantwortung für jeden einzelnen.

 

 

Enquiries:

Medtrade Products Limited

Tel: +44 (0)1270 500019

Email: info@celoxpph.com

• rohmann@dahlhausen.de – Dirk Rohmann, Member of the Board, Dahlhausen
• sutcliffe@medtrade.co.uk – Andy Sutcliffe, Global Strategic Marketing Director, Medtrade

 

* See IFU instructions for use for intended use, contraindications, warnings and precautions: available at www.celoxpph.com